Light Microscopic Detection of BCR-ABL Transcripts after In-Cell RT-PCR: Fusion Gene Expression Might Correlate with Clinical Evolution of Chronic Myeloid Leukemia

References

• Nowell P. C., Hungerfold D. A. A minute chromosome in human granulocytic leukemia. Science 1960; 32: 1497–1501
   Google Scholar
• Rowley J. D. A novel consistent chromosome abnormality in chronic myelogenous leukemia detected by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Melo J. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375–2384
   PubMed Web of Science ®Google Scholar
• de Klein A., van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D., Spurr N. K., Heisterkamp N., Groffen J., Stepherson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982; 300: 765–767
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stephenson J. R., Groffen J., Hansen P. R, de Klein A., Bertran C. R. Localisation of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Roe B. A., Canaani E. Fused transcript of abl and bcr genes in chronic myeloid leukemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Chan L. L., Karhi K. K., Rayter S. I., Heisterkamp N., Eridani S., Powles R., Lawler S. D., Groffen J., Foulkes J. G., Greaves M. F., Wiedemann L. M. A novel ABL protein expressed in Philadelphia positive acute lymphoblastic leukemia. Nature 1987; 325: 631–635
   PubMed Web of Science ®Google Scholar
• Hochhaus A., Reiter A., Sklapny H., Melo J. V., Sick C., Berger U., Guo J. Q., Arlinghaus R. B., Hehlmann R., Goldman J. M., Cross N. C.P. A novel BCR-ABL fusion gene (e6a2) in a patient with Philapelphia chromosome negative chronic myelogeneous leukemia. Blood 1996; 88: 2236–2240
   PubMed Web of Science ®Google Scholar
• Okamoto K., Karasawa M., Sakai H., Ogura H., Morita K., Naruse K. A novel acute lymphoid leukemia type BCR/ABL transcript in chronic myelogenous leukemia. British Journal of Haematology 1997; 96: 611–613
   PubMed Web of Science ®Google Scholar
• Saglio G., Guerrasio A., Rosso C., Zaccaria A., Tassinari A., Serra A., Rege-Cambrin G., Mazza U., Cavosto F. New type of BCR/ABL junction in Philadelphia chromosome positive leukemia. Blood 1990; 76: 1819–1824
   PubMed Web of Science ®Google Scholar
• Guerrasio A. Molecular insights in chronic myeloid leukemia and in other Ph positive human leukemias. Reviews in Clinical and Experimental Hematology 1997; 2: 52–75
   Google Scholar
• Sklar J. L., Costa J. G. Principles of cancer management: Molecular pathology. Principles and practice of oncology, V. De Vita, S. Hellman, S. Rosenberg. Lippincott-Raven Publishers, Philadelphia 1997; 59–84
   Google Scholar
• Radich J., Gehly G., Cooley T., Bryant E., Clift R. A., Collins S., Edmans S., Kirk J., Lee A., Kessler P., Schoch G., Buchner C. D., Sullivan K. M., Appelbaum F. R., Thomas E. D. PCR detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 13: 1704–1713
   Google Scholar
• Nolte M., Werner M., Ewig M., et al. Megakaryocytes carry the fused BCR-ABL gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies. Virchows Archives 1996; 427: 561–565
   PubMed Web of Science ®Google Scholar
• Sinclair P. B., Green A. R., Grace C. D., Proffitt J., Wilber K., Nacheva E. P. (1997) Triple probe three colour FISH system for BCR-ABL detection – further improvements. Proceedings of the 39th Annual Meeting of the American Society of Hematology, San Diego, 1997, Abstract 355
   Google Scholar
• Gabert J., Lafage M., Maraninchi D., Thuret I., Carcassonne Y., Manoni P. Detection of residual bcr/abl translocation by polymerase chain reaction in myeloid leukemia patients after bone-marrow transplantation. Lancet 1989; 11: 1125–1128
   Google Scholar
• Melo J. V., Hochhaus A., Yan X. H., Goldman J. M. Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia. British Journal of Haematology 1996; 92: 684–686
   PubMed Web of Science ®Google Scholar
• Costello R., Kirk J., Gabert J. Value of PCR analysis for long term survivors after allogeneic bone marrow transplant for chronic myelogenous leukemia: A comparative study. Leukemia and Lymphoma 1996; 20: 239–243
   PubMed Web of Science ®Google Scholar
• van Rhee F., Lin F., Cross N. C., Reid C. D., Lakhani A. K., Szydlo R. M., Goldman J. M. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplantation 1994; 14: 609–612
   PubMed Web of Science ®Google Scholar
• Lion T. Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia Group. Bone Marrow Transplantation 1994; 14: 505–509
   PubMed Web of Science ®Google Scholar
• Testoni N., Martinelli G., Farabegoli P., Zaccaria A., Amabile M., Raspadori D., Pelliconi S., Zuffa E., Carboni C., Tura S. A new method of “in-cell reverse transcriptase-polymerase chain reaction” for the detection of BCR/ABL transcript in chronic myeloid leukemia patients. Blood 1996; 87: 3822–3827
   PubMed Web of Science ®Google Scholar
• Pachmann K., Zhao S., Kantarjian H., Andreeff M., et al (1997) In situ amplification of BCR-ABL sequences for analysis of mRNA expression at the single cell level in chronic myeloid leukemia. Proceedings of the 39th Annual Meeting of the American Society of Hematology, San Diego, 1997, Abstract 4008
   Google Scholar
• Preudhomme C., Chams Eddine L., Roumier C., Soenen V., Lai J. L., Cosson A., Fenaux P. (1997) In situ RT-PCR for the detection of BCR-ABL transcript in chronic myeloid leukemia: comparison with conventional cytogenetic, FISH and RT-PCR results. Proceedings of the 39th Annual Meeting of the American Society of Hematology, San Diego, 1997, Abstract 4012
   Google Scholar
• Chang C., Glassman A. B., Bueso-Ramos C. E. Applicability of direct in situ reverse-transcription-polymerase chain reaction on bone marrow smears. Ann Clin Lab Sci 1998; 28: 34–42
   PubMed Web of Science ®Google Scholar
• Bales C. E., Durfee G. R. Cytologic Techniques. Diagnostic Cytology and its Histopathologic Bases, 4th ed., L. G. Koss. J. B. Lippincott, Philadelphia 1992; 1452–1515
   Google Scholar
• Patel V. G., Shum-Siu A., Heniford B., Wieman T., Hendler F. Detection of epidermal growth factor receptor mRNA in tissue sections from biopsy specimens using in-situ polymerase chain reaction. Am J Pathol 1994; 144: 7–14
   PubMed Web of Science ®Google Scholar
• Costello R., Lafage M., Toiron Y., Brunei V., Sainty D., Arnoulet C., Mozziconacci M. J., Bouabdallah R., Gastaut J. A., Maraninchi D. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases. British Journal of Haematology 1995; 90: 346–352
   PubMed Web of Science ®Google Scholar
• San Miguel J., van Dongen J., Bartram C., Parreira A., Wormann B., . Investigation of minimal residual disease (MRD) in acute leukemia (AL): International standardization and evaluation. Cancer Research Supported under BIOMED 1, S. Baig, et al. IOS Press, Amsterdam 1998; 300–306
   Google Scholar
• Zou W., Durand-Gasselin I., Dulioust A., Maillot M-C, Galanaud P., Emilie D. Quantification of cytokine gene expression by competitive PCR using colorimetric assay. European Cytokine Network 1995; 6: 257–264
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S., Clark S. S., Coyne M. Y., Smith S. D., Champlin R., Witte O. N., McCormic F. P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proceedings of the National Academy of Science of USA 1988; 85: 5698–5702
   PubMed Web of Science ®Google Scholar
• Chomezynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Kwok S., Higushi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
   PubMed Web of Science ®Google Scholar
• Komminoth P., Long A. In-situ polymerase chain reaction. An overview of methods, applications and limitations of a new molecular technique. Virchows Archives B 1993; 64: 67–73
   Web of Science ®Google Scholar
• Teo I. A., Shaunak S. Polymerase chain reaction in situ: an appraisal of an emerging technique. Histochemistry Journal 1995; 27: 647–659
   Google Scholar
• Crisan D., Chen S-T., Weil S. C. Polymerase chain reaction in the diagnosis of chromosomal breakpoints. Hematology/Oncology Clinics of North America 1994; 8: 725–751
   PubMed Web of Science ®Google Scholar
• Jinno Y., Yoshiura K., Niikawa N. Use of psoralen as extinguisher of contaminated DNA in PCR. Nucleic Acid Research 1990; 18: 6739
   PubMed Web of Science ®Google Scholar
• Wetzler M., Talpaz M., van Etten R. A., Hirsh-Ginsberg C., Beran M., Kurzrock R. Subcellular localization of bcr, abl and BCR-ABL proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. Journal of Clinical Investigation 1993; 92: 1925–1931
   PubMed Web of Science ®Google Scholar
• Wetzler M., Kurzrock R., Lowe D. G., Kantarjian H., Gutterman J. U., Talpaz M. Alteration in bone marrow adherent layer growth factor expression: A novel mechanism of chronic myelogenous leukemia progression. Blood 1991; 78: 2400–2407
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Goldman M. J. Cellular and molecular mechanisms in chronic myeloid leukemia: Biology and treatment. British Journal of Haematology 1996; 95: 10–20
   PubMed Web of Science ®Google Scholar
• Keating A., Wang X-N, Laraya P. Variable transcription of BCR-ABL by Ph- cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood 1994; 83: 1744–1749
   PubMed Web of Science ®Google Scholar
• Gotoh A., Broxmeyer H. E. The function of BCR/ABL and related protooncogenes. Current Opinion in Hematology 1997; 4: 3–11
   PubMedGoogle Scholar
• Saglio G., Pane F., Martinelli G., Guerrasio A. Bcr/abl transcripts and leukemia phenotype: An unsolved puzzle. Leukemia and Lymphoma 1997; 26: 281–286
   PubMed Web of Science ®Google Scholar
• Collins S., Kubonishi I., Miyoshi I., Groudine M. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science 1984; 225: 72–74
   PubMed Web of Science ®Google Scholar
• Kelliher M., Knott A., McLaughlin J., Witte O. N., Rosenberg N. Differences in oncogenic potency but not target cell specifity distinguish two forms of BCR/ABL oncogene. Molecular Cell Biology 1991; 11: 4710–4718
   PubMed Web of Science ®Google Scholar
• Williamson I., Gautier D., Leibowitz D. (1996) BCR/ABL expression is decreased when a downstream silencer is present on the PHI chromosome. Proceedings of the 38th Annual Meeting of the American Society of Hematology, Orlando, 1996, Abstract 2279
   Google Scholar
• Dreazen O., Berman M., Gale R. P. Molecular abnormality of BCR and ABL in chronic myelogenous leukemia associated with long chronic phase. Blood 1988; 71: 797–804
   PubMed Web of Science ®Google Scholar
• Biernaux C., Loos M., Sels A., Huez G., Stryckmans P. Detection of major BCR-ABL gene expression at a very low level in blood cells of some healthy individuals. Blood 1995; 86: 3118–3122
   PubMed Web of Science ®Google Scholar
• Lion T., Izraeli S., Henn T., Gaiger A., Morr W., Gadner H. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 1990; 6: 495–501
   Web of Science ®Google Scholar
• Gaiger A., Henn T., Horth E., Geissler G., Mitterbauer G., Maier-Dobersberger T., Greinix H., Mannhalter C., Haas O. A., Lechner K., Lion T. Increase of BCR/ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 1995; 86: 2371–2378
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Talpaz M., Walters R. S., Smith T. L., Cork A., McCredie K. B., Freireich E. J. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. American Journal of Medicine 1987; 83: 445–454
   PubMed Web of Science ®Google Scholar
• Cabot G. F., Bentz M., Scholl C., Moos M., Fischer K., Lichter P., Dohner H. High incidence of a second BCR/ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genetics and Cytogenetics 1996; 87: 107–111
   PubMed Web of Science ®Google Scholar
• Guerrasio A., Serra A., Gottardi E., Cilloni D., Vischia F., Parvis G., Cilly V., Saglio G. Molecular events in chronic myeloid leukemia progression. Leukemia 1995; 11: 519–521
   Google Scholar